Un tratament revoluționar reduce colesterolul „rău” cu peste 60% cu o singură doză. „Tehnologia funcționează”

A recent study shows that a single dose of an experimental gene therapy significantly lowers LDL cholesterol levels by up to 62%, lasting for nearly a year. This treatment, called VERVE-102, modifies a gene responsible for cholesterol regulation and may eliminate the need for daily medication. Researchers reported no serious safety issues during the trial, published in The New England Journal of Medicine. If larger studies confirm its safety and efficacy, this therapy could provide long-term cardiovascular protection.